chrisvoncsefalvay/vaers-outcomes huggingface dataset:
01/06/2023 participated in 800 meter race and 3 hours later was still experiencing tachycardia and heart palpitations. At times we could feel her heart beating seemingly forcefully. 01/13/2023 went in to see PCP and was referred to cardiologist. Go to cardiologist on 02/02/2023. Still experiences intermittent palpitations and tachycardia after exercising lasting for 10-12 hours.
Sharp pain bilaterally to lower back pain lasting 5-10 minutes. Gave 50g BENADRYL.
This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (booster dose on 21Sep2021), MIGRAINE (migraine), PAIN IN EXTREMITY (right arm pain), TREMOR (mild tremors) and PYREXIA (fevering) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048F21A, 027A21A and 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter.  The patient's past medical history included COVID-19 (Nov/Dec 2019 that lasted for 3 months. Treated with oxygen and stated she is still not fully recovered from the infection.) in November 2019. Concurrent medical conditions included Drug allergy (Allergy to Haldol), Drug allergy (Allergy to tramadol), Drug allergy (Allergy to indomethacin), Latex allergy (latex), Drug allergy (Allergy to cillin), Drug allergy (Allergy to hydrocodone), Drug allergy (Allergy to cephalexin), Drug allergy (Allergy to promethazine), Drug allergy (Allergy to venlafaxine), Food allergy (Allergy to coffee), Allergy (Allergy to lavender), Allergy (Allergy to the sun), Atrial fibrillation, Type 2 diabetes mellitus, Migraine (all types of Migraines), Trigeminal neuralgia (b1, b2, b3.), Solar urticaria, Ulcer bleeding gastric, MTHFR gene mutation (two strains) and Fibromyalgia. Concomitant products included LEVOTHYROXINE, SIMVASTATIN, VITAMIN D [VITAMIN D NOS], FISH OIL (OMEGA 3 [FISH OIL]), PANTOPRAZOLE, DIGOXIN, METOPROLOL, METFORMIN, LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D), IBUPROFEN, PARACETAMOL (TYLENOL [PARACETAMOL]), MECLIZINE [MECLOZINE], POTASSIUM, FUROSEMIDE and GLYCERYL TRINITRATE (NITROSTAT) for an unknown indication. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Sep-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (booster dose on 21Sep2021), MIGRAINE (migraine), PAIN IN EXTREMITY (right arm pain), TREMOR (mild tremors), PYREXIA (fevering), MYALGIA (severe achiness lasted about 3 to 5 days total) and HEADACHE (a sore head). In September 2021, MIGRAINE (migraine), PAIN IN EXTREMITY (right arm pain), PYREXIA (fevering), MYALGIA (severe achiness lasted about 3 to 5 days total) and HEADACHE (a sore head) had resolved. On 21-Sep-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (booster dose on 21Sep2021) had resolved. At the time of the report, TREMOR (mild tremors) outcome was unknown. No Treatment information was provided. Concomitant information include Butalbital/ Caffeine/ APAP/Codeine. This case was linked to MOD-2021-422324, MOD-2021-422307 (Patient Link).
Pain, swelling, erythema Left arm at site of Pneumoccal. Area extreme swelling 12 cm long by 7 cm wide from injection site Left arm to elbow.
Numbness is both legs from the knees down. Feels like legs are asleep.  Had IV/IG drip given 06/24/2021. No improvement to date
Heart palpitations, chest discomfort and tightness in left side - started on  3/12/2021 and have been ongoing and intermittent since that time
Mild fever of at least 100.4-102 x 10days, Tiredness, weakness, dizziness, aches & pains, headache, localized soreness @ injection site.
Rash, painful, crusty vesicular lesions right upper arm, palm, between fingers.  Treatment:  Acyclovir, Neosporin.
Felt like I was in a fog, head swimming. Dizzy, hot flashes. Head and nack numb! When I touch my head it is tingly. Very tired. Irritable, anxiety, no fever, hungry but nauseated after a couple of bites of food, when going to sleep--almost asleep then a rush of adrenaline with wake me up and my heart will be racing. Feels like I'm in a dream--surreal--like I'm high on something, very unpleasant.
Patient was given Fluzone on on 9/2/23 and came to the pharmacy to get Covid vaccine.  However, instead of requesting  a Covid vaccine, she said "Flu vaccine."  The system was down at time .  Pharmacist took patient word for it and gave the patient a second dose of flu vaccine (Flublok).  After speaking with the patient, she is doing physically well after our conversation and no adverse affects.
Pt Developed rash approx 2 to 3 wks following smallpox vaccination. Described as mac/pap without vesicles with itching. Onset 1 Sep 05. Treated with IV Benadryl. ? early EM minor or folliculitis.
Approximately 8 weeks after receiving the 2nd Covid-19 injection in my Left arm, I woke up and my left arm was extremely painful at the injection site. Just as painful as it was the day I had my first injection.  There was a hardened area around the injection site that was  the entire width of my arm and about 2 " wide.  No redness or warmth.  I decided to try to massage the area and when I did, a very loud/audible CRUNCHING sound could be heard.  It sounded like i was pushing on broken glass in my arm.  My arm would ache down to my elbow after doing that.  The harness and pain lasted about 2 weeks. The crunching improved but never went away. Now today, 12 weeks after the injection, my arm is starting to hurt again.  No lump, but definitely an aching pain shooting down my arm, and an increase in the crunching/crackling sound.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2010, the patient was inoculated with ZOSTAVAX by a physician for routine adult health maintenance and the intended purpose for the prevention of shingles. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster, the very virus the ZOSTAVAX vaccine was intended to prevent. In 2014, the patient was treated by the same physician for a vesicular outbreak which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment.  As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown.  Causality assessment was related. Additional information has been requested.
10 days after receiving vaccine, I developed chest pains and shortness of breath. All the symptoms of a heart attack. Felt like a 200 pound of pressure on my chest. After 10 days I felt fine with no lingering pressure or pain.
This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (had a headache for half a day) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced HEADACHE (had a headache for half a day). In 2021, HEADACHE (had a headache for half a day) had resolved. Concomitant medication was not reported. Patient had a headache for half a day after receiving booster late last year (2021). Patient received the first dose of the Moderna COVID-19 vaccine in February or March and received Moderna COVID-19 Booster late in the year. Patient was not sure of exact dates. Treatment medication was not reported. This case was linked to MOD-2022-533524, MOD-2022-533526 (Patient Link).
This spontaneous report was received from a medical assistant referring to an unspecified number of patients of unspecified demographics. Information regarding the patients' pertinent medical history, drug reactions or allergies and concomitant therapies was not provided. On unknown dates, the unspecified number of improperly stored doses of GARDASIL 9, lot # M041990 with expiration date on 28-JUN-2019  (dose, route of administration and anatomical location were not reported) were administered to the unspecified number of patients. No adverse effects were reported. The temperature excursion was recorded via Digital Data Logger. It was reported that the vaccines were exposed to temperature of 29.7 degrees Fahrenheit for 60 days before administration to the patients. No previous temperature excursion was reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1705USA012910: US-009507513-1705USA009653:
Muscle soreness; Rash on fingers; Aches in both shoulder; Exhaustion; Intestinal distress; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 01Mar2021 at 14:15 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes and pancreatic cancer. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included ezetimibe (MANUFACTURER UNKNOWN); taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an unspecified route of administration in the left arm on 29Jan2021 at 14:30 as a single dose for COVID-19 immunisation. On 08Mar2021, the patient experienced muscle soreness, rash on fingers, aches in both shoulder, exhaustion and intestinal distress. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event rash on fingers and included treatment with unspecified steroid and topical. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events muscle soreness, rash on fingers, aches in both shoulder, exhaustion and intestinal distress were resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
A nurse reported the occurrence of an injection site reaction in a 25 year old female who was vaccinated with hep B vaccine recombinant (Engerix B) for prophylaxis. The subject's medical history, concurrent conditions, and concurrent medications were unknown. On 1/9/03, the subject received her second injection of Engerix B (5285C6). Approximately 24 hrs later, on 1/10/03, the subject experienced an injection site reaction characterized by redness and swelling the "size of a baseball." The subject was seen by the physician, who prescribed Benadryl. On an unspecified date, the event resolved.
Severe headache across forehead; This is a spontaneous report from a contactable consumer, the patient. An 83-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208), via an unspecified route of administration in the left arm on 23Mar2021 at 12:00 (at the age of 83-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021, around 10 days after the second shot, the patient experienced severe headache across the forehead. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event severe headache across the forehead was resolved on an unknown date in Apr2021.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Fever; headache; chills; diarrhea; stomach cramps; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 50-years-old non-pregnant female patient received second dose of bnt162b2 (Pfizer covid 19, formulation: solution for injection, Batch/Lot Number: EL3247), via an unspecified route of administration, administered in Arm Left on 18Feb2021 14:00 (at the age of 50-years-old) as DOSE 2, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient had no allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included colecalciferol (VITAMIN D [COLECALCIFEROL]) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection; Lot Number: EL3247), via an unspecified route of administration in Arm left on 28Jan2021 11:30AM as dose 1, single for COVID-19 immunization. On 19Feb2021 04:00, the patient experienced fever, headache, chills, diarrhea, stomach cramps. The patient underwent lab tests and procedures which included body temperature: 100 fahrenheit on an unspecified date. Patient did not received treatment for adverse events. The outcome of the events was recovered on an unspecified date of 2021.  Follow-up (17Jun2021): Follow-up attempts completed. No further information expected.
female who presents with complaint of a dry cough and dyspnea.  She denies fever chills chest pain orthopnea paroxysmal nocturnal dyspnea palpitations syncope or peripheral edema.  Her dyspnea had onset 2-3 days ago and has progressively worsened.  Patient does have a history of COPD   12/30/21 Pfizer EJ1646 1/20/21 Pfizer EL3249   x3 covid vaccines given to patient by nursing home:  2/10/21 Pfizer EN5318
pt recvd 2nd dose of vax in JUN & devel burning sensation w/inject w/soreness &/or aching in arm; This sensation persisted assoc w/a feeling of heaviness in the arm which lasted x 24 hrs; pt denied fever, local swelling or erythemia
The evening after vaccine exp fever, headache,muscle cramps and cold sweats. On 4/7 I broke out in a rash and on 4/14  doctor told I have Shingles. My estimated date of delivery (9/14/2021).
3 days after receiving Tdap vaccine patient reports to student health stating that since she received the Tdap a red circular spot on skin has been spreading across her uppper right arm.  The area was red, har, slightly raised and warm to touch. Doctor assessed area as a Local soft tissue infection. DX. Cellulitis treated with Keflex 500 mg one capsule every 12 hours for 7 days and to apply cool compresses to the area also.
With all three Moderna shots, I had the worst headaches of my life and violent throwing up for 12 hours.   My husband had all three shots at the same time and barely felt bad. Health professionals can?t tell me if I?m allergic to a component and if it?s dangerous to get another shot.  After my first one, I went to Urgent Care for a pain shot and nausea , but that only lasted a few hours and the headache was right back. After shots two and three, I took my own leftover medication.  What?s a person supposed to do when they know ahead of time they are going to be so sick? What should my dr prescribe?  I?m all current on my shots and only had a sore arm from the other shots.
Vertigo, nausea, dizziness, loss of equilibrium since Sunday 3/14
41 year old female received H1N1 and seasonal flu vaccine (one in each deltoid muscle) on 1/28/2010 at 9 AM.  At 10 AM she developed intermittent abdominal cramping. This continued for 24 hours.  She also had increased gas, nausea but no vomiting. She stated she had normal bowel and bladder habits and was eating and drinking as normal.  She denied a fever.  She also stated she had not recently changed her diet or lifestyle habits. Her abdominal symptoms all resolved after 2 days.
On 7/21/21 @ 1320hrs: The patient told the medical staff member at the event that she wanted to receive her second dose of the covid vaccine. It was reported she last received Moderna on 4/02/21. She was asked if she would like to reschedule for another event that had the Moderna vaccine. She stated "I work at this facility and can't leave. Since you guys are here I want to get the Pfizer shot and be done." The patient was requesting the Pfizer vaccine. She was educated on the policy for mixing mRNA vaccines. She verbalized understanding and continued to ask for Pfizer. She was vaccinated with Pfizer Lot: EW0177 on 7/21/21. No adverse or allergic reaction was reported during the monitoring phase of the event.
Patient had 30-minute generalized tonic clonic seizure the following morning at 3 AM requiring admission to the hospital.
Administered after the vaccine had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered after the vaccine had expired) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 016B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered after the vaccine had expired). On 21-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Administered after the vaccine had expired) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided. Reporter reported that None of the patients experienced any reported symptoms.   This case was linked to MOD-2021-413535, MOD-2021-413554 (Patient Link).
This spontaneous report was received from a medical assistant refers to an unspecified number of patients of unknown age and gender. On unknown date the patients were vaccinated with a dose of improperly stored RECOMBIVAX HB (dose, route of administration and lot # were not reported). This vaccine had been exposed to 32F for 2.5 hours. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
High fever 103 degrees, headaches, soreness and swelling of left arm with limited movement as of 09/01/2018. Appetite loss, weight loss.
Low grade fever, chills, body aches, nausea, abdominal pain, diarrhea, confsion, weakness. Unable to get out of bed, stand or walk independently per baseline. Onset within 11 hours of dose with resolution except for leg pain 48 hours after administration
Soreness; Migraine headaches; Dizziness; Panic attack; pain at the injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness), MIGRAINE (Migraine headaches), DIZZINESS (Dizziness), PANIC ATTACK (Panic attack) and VACCINATION SITE PAIN (pain at the injection) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included Panic attacks and Surgery (Minor surgery) on 18-Jan-2021. Concurrent medical conditions included Chronic migraine and Allergy (Allergic to nickel due to metal implant in heart).    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Soreness), MIGRAINE (Migraine headaches), DIZZINESS (Dizziness), PANIC ATTACK (Panic attack) and VACCINATION SITE PAIN (pain at the injection). At the time of the report, PAIN (Soreness) and VACCINATION SITE PAIN (pain at the injection) had resolved and MIGRAINE (Migraine headaches), DIZZINESS (Dizziness) and PANIC ATTACK (Panic attack) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 04-Feb-2021: No specific follow-up information recorded.
pt recv vax 1OCT97 & 3OCT97 rt upper arm is now swollen, red, & warm to touch;current dx r/o cellulitis vs local tissue rxn;
fever 102-104 1wk p/vax;rash on abd began 9 days p/vax;
Ten days after the vaccine I noticed that my left arm was swollen and red around the area of the shot. Over the course of a few days it seemed to clear from the middle out. It seemed to clear from the injection site and then radiate out until it dissipated after three or four days. I had consulted with a telemedicine professional. I got the second shot in the same arm and I did not have a similar experience.
This case was reported by a nurse and described the occurrence of wrong vaccine administered in a male patient who received FLUARIX QUADRIVALENT (batch number LY2F5, expiry date 30th June 2015). On an unknown date, the patient received FLUARIX QUADRIVALENT .5 ml. On an unknown date, an unknown time after receiving FLUARIX QUADRIVALENT, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. Additional information received: There were 2 patients that were inadvertently administered the 0.5mL dose of FLUARIX QIV who were less than 3 YO. The nurse only had patient specific and lot specific information for only 1 of the two patients at the moment.
acute cerebellar ataxia; 60 day follow-up received on 10/4/00 states that the pt has recovered.
Vomiting, dizziness, vitals wnl. Anxiety, fear leading up to vaccine. Water was provided.
Pt developed a 1 - 1 1/5cm area of redness, swelling, noted on 4/4/00. Swelling noted to be 1 inch below injection site.
Redness, swelling and warmth that measured 5cm x 6cm, that started on 2/25/2000, at site of DTAP. Pt able to do full ROM, some slight soreness of lymph nodes. General lymphadenopathy more on right side of arm; skin rash, general erythema. No sore throat.
Received shot on Tuesday AM. Saturday AM problems breathing and talking. Continued on to a very bad head and chest cold with fever and headaches. I am rarely sick and never this bad. Would just as soon have the flu. It's been a month now and I still have these problems. Should not give people stuff like this.
Patient's family member called the pharmacy today regarding the patient having redness at the site of the vaccination, itchy and swollen.  No other associated symptoms.  Will follow up with the patient on Monday.  Patient took Zyrtec and will use hydrocortisone cream at the injection site area if still itchy.